SyntekaBio

SyntekaBio uses artificial intelligence to help drug researchers find and refine promising drug candidates faster, its platforms analyse three-dimensional protein structures and large-scale genomic data to screen compounds and identify targets.

Listed on KOSDAQ, Korea's tech-focused stock exchange, it supplies these AI-driven drug-discovery services to pharmaceutical and biotech clients, and its genomic precision-medicine platform is already generating revenue through domestic university hospitals. Its own internal drug pipeline, covering synthetic drugs, drug repurposing, and antibody therapies, runs alongside the platform services business.